Doseology Sciences Inc. (DOSEF)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 99.19 Thousand CAD | -88.62% |
| 2021 | 871.5 Thousand CAD | -74.47% |
| 2020 | 3.41 Million CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 5240.00 CAD | -94.48% |
| 2023 Q1 | 94.87 Thousand CAD | -4.35% |
| 2022 FY | 99.19 Thousand CAD | -88.62% |
| 2022 Q4 | 99.19 Thousand CAD | -80.22% |
| 2022 Q3 | 501.58 Thousand CAD | -16.64% |
| 2022 Q2 | 601.72 Thousand CAD | -1.71% |
| 2022 Q1 | 612.21 Thousand CAD | -29.75% |
| 2021 Q1 | 3.07 Million CAD | -9.84% |
| 2021 FY | 871.5 Thousand CAD | -74.47% |
| 2021 Q4 | 871.5 Thousand CAD | -4.47% |
| 2021 Q3 | 912.33 Thousand CAD | -0.42% |
| 2021 Q2 | 916.18 Thousand CAD | -70.23% |
| 2020 Q4 | 3.41 Million CAD | 0.0% |
| 2020 FY | 3.41 Million CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | 99.814% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | 98.965% |
| SQZ Biotechnologies Company | 50.03 Million USD | 99.802% |
| Evofem Biosciences, Inc. | 72.47 Million USD | 99.863% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | 99.832% |
| Mesoblast Limited | 188.44 Million USD | 99.947% |
| Propanc Biopharma, Inc. | 3.85 Million USD | 97.425% |
| Genus plc | 485 Million USD | 99.98% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | 98.302% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | 96.058% |
| Marizyme, Inc. | 26.67 Million USD | 99.628% |
| ContraFect Corporation | 32.53 Million USD | 99.695% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | 97.39% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | 94.994% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | 97.409% |
| Intellipharmaceutics International Inc. | 12 Million USD | 99.174% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | 99.158% |
| MultiCell Technologies, Inc. | 1617.67 USD | -6031.658% |
| Accustem Sciences Inc. | 1.07 Million USD | 90.809% |
| RVL Pharmaceuticals plc | 77.41 Million USD | 99.872% |
| EV Biologics, Inc. | 2.11 Million USD | 95.31% |
| Q BioMed Inc. | 8.13 Million USD | 98.78% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | 99.88% |
| Neon Bloom, Inc. | 1.22 Million USD | 91.911% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | 98.072% |
| Biomind Labs Inc. | 1.49 Million USD | 93.381% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 244.07 Million USD | 99.959% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | 99.461% |
| Skye Bioscience, Inc. | 14.07 Million USD | 99.295% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | 95.065% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | 30.195% |
| Arch Therapeutics, Inc. | 9.46 Million USD | 98.952% |
| IMV Inc. | 37.93 Million USD | 99.739% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | 50.68% |
| Curative Biotechnology, Inc. | 5.74 Million USD | 98.274% |
| GB Sciences, Inc. | 5.41 Million USD | 98.169% |
| Alpha Cognition Inc. | 7.16 Million USD | 98.616% |
| HST Global, Inc. | 593.59 Thousand USD | 83.29% |
| CSL Limited | 18.62 Billion USD | 99.999% |
| Halberd Corporation | 728.71 Thousand USD | 86.388% |
| Enzolytics Inc. | 365.26 Million USD | 99.973% |
| Resverlogix Corp. | 67.39 Million USD | 99.853% |
| Affymax, Inc. | 8.87 Million USD | 98.882% |
| SYBLEU INC | 681.41 Thousand USD | 85.443% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | 88.174% |
| argenx SE | 444.95 Million USD | 99.978% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | 99.868% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | 94.213% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | 99.167% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | 97.294% |
| AVAX Technologies, Inc. | 3.99 Million USD | 97.516% |
| Zenith Capital Corp. | 27.56 Thousand USD | -259.788% |
| Genscript Biotech Corporation | 1.32 Billion USD | 99.993% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | 58.438% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | 97.344% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | 85.431% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 99.916% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | 98.903% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -48.202% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | 93.082% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | 99.803% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | 96.342% |
| BioStem Technologies, Inc. | 15.9 Million USD | 99.376% |
| ONE Bio Corp. | 27.49 Million USD | 99.639% |
| Reve Technologies, Inc. | 464.69 Thousand USD | 78.655% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -261.572% |
| Wesana Health Holdings Inc. | 1.25 Million USD | 92.123% |
| Agentix Corp. | 2.51 Million USD | 96.049% |
| LadRx Corporation | 2.2 Million USD | 95.492% |
| Cell Source, Inc. | 15.8 Million USD | 99.372% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -121.921% |
| Regen BioPharma, Inc. | 5.45 Million USD | 98.183% |
| Regen BioPharma, Inc. | 5.45 Million USD | 98.183% |
| NovAccess Global Inc. | 7.86 Million USD | 98.738% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | 99.599% |
| Itoco Inc. | 1.65 Million USD | 94.0% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | 95.165% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | 98.36% |
| Kadimastem Ltd | 3.5 Million USD | 97.17% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | 76.471% |
| CytoDyn Inc. | 127.89 Million USD | 99.922% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -137.302% |
| Mobile Lads Corp. | 1.31 Million USD | 92.448% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | 93.668% |
| Qrons Inc. | 1.48 Million USD | 93.337% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | 99.102% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | 87.736% |
| Rebus Holdings, Inc. | 5.24 Million USD | 98.108% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | 98.374% |
| International Stem Cell Corporation | 5.27 Million USD | 98.12% |
| Bioxytran, Inc. | 3.24 Million USD | 96.948% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | 84.15% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | 97.852% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | 99.758% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | 99.555% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | 95.103% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | 98.189% |
| Neutra Corp. | 973.52 Thousand USD | 89.811% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | 99.658% |
| PureTech Health plc | 125.58 Million USD | 99.921% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | 97.36% |
| IXICO plc | 1.9 Million USD | 94.78% |
| IntelGenx Technologies Corp. | 20.52 Million USD | 99.517% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 99.904% |
| CSL Limited | 18.62 Billion USD | 99.999% |
| Cellectis S.A. | 249.36 Million USD | 99.96% |